| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 11/01/2006 | CN1856304A Derivatives of N-(1H-indazolyl)- and N-(1H-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (VR1) for the treatment of pain |
| 11/01/2006 | CN1854137A Method for resoluting zopiclone |
| 11/01/2006 | CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 11/01/2006 | CN1282906C Electronic photograph organic photoreceptor having novel charge migration compound |
| 11/01/2006 | CN1282644C Indane or indoline derivative |
| 11/01/2006 | CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same |
| 10/31/2006 | US7129374 Catalytic antioxidants and methods of use |
| 10/31/2006 | US7129264 anticoagulants; antiinflammatory agents; cardiovascular disorders |
| 10/31/2006 | US7129263 Preparation of 3-azabicyclo [3.1.0] hexane derivatives |
| 10/31/2006 | US7129260 Isoindolinone kinase inhibitors |
| 10/31/2006 | US7129253 Compounds |
| 10/31/2006 | US7129250 Neuroprotective and anti-proliferative compounds |
| 10/31/2006 | US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 10/31/2006 | US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
| 10/31/2006 | US7128896 using carbocyanine dyes; photodynamic therapy; in vivo supplying to tumor |
| 10/31/2006 | CA2246126C New piperazine compounds |
| 10/31/2006 | CA2186508C Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 10/26/2006 | WO2006113864A2 Oxindole compounds and their uses as therapeutic agents |
| 10/26/2006 | WO2006113650A1 Design and synthesis of novel tubulin polymerization inhibitors: bonzoylphenyluria (bpu) sulfur analogs |
| 10/26/2006 | WO2006112549A1 Fused heterocyclic compound |
| 10/26/2006 | WO2006112479A1 Nitrogen-containing heterocyclic compound |
| 10/26/2006 | WO2006111726A1 Water soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents |
| 10/26/2006 | WO2006111648A1 H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use |
| 10/26/2006 | WO2006043263A3 Ultraviolet protected polyethersulfones |
| 10/26/2006 | WO2005106011A3 Process for preparing dipeptidyl iv inhibitors and intermediates therefor |
| 10/26/2006 | WO2005072408A3 Treating a viral disorder |
| 10/26/2006 | WO2003006628A3 Nad synthetase inhibitors and uses thereof |
| 10/26/2006 | US20060241301 Urea derivatives and their use as tyrosinkinase inhibitors |
| 10/26/2006 | US20060241259 for photopolymerization; photography, relief imaging; color filters |
| 10/26/2006 | US20060241167 Crystalline polymorph Form G, formed by filtering Fluvastatin sodium off from an aqueous suspension. |
| 10/26/2006 | US20060241119 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 10/26/2006 | US20060241116 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 10/26/2006 | DE4244539B4 Duale Inhibitoren der No-Synthese und Cyclooxygenase, Verfahren zu ihrer Herstellung und therapeutische Präparate, die sie enthalten Dual inhibitors of NO synthesis and cyclooxygenase, processes for their preparation and therapeutic compositions containing them |
| 10/26/2006 | CA2610446A1 Nitrogen-containing heterocyclic compound |
| 10/26/2006 | CA2606174A1 Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs |
| 10/26/2006 | CA2605778A1 Fused heterocyclic compound |
| 10/26/2006 | CA2605059A1 Oxindole compounds and their uses as therapeutic agents |
| 10/26/2006 | CA2604920A1 Novel compounds useful for bradykinin b1 receptor antagonism |
| 10/25/2006 | EP1713771A1 New crystalline form of perindopril |
| 10/25/2006 | EP1713770A1 Selective estrogen receptor modulators |
| 10/25/2006 | EP1713474A1 Indirubin derivatives having anticancer property against human cancer cell me |
| 10/25/2006 | EP1517909B1 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 10/25/2006 | EP1301520B8 Ligands, complex compounds and their use for polymerising olefins |
| 10/25/2006 | EP1286672B1 S-methyl-dihydro-ziprasidone for the treatment of ocular disorders. |
| 10/25/2006 | EP1265606B1 Cell adhesion inhibitors |
| 10/25/2006 | CN1852906A Novel compounds |
| 10/25/2006 | CN1852744A Endoluminal prosthesis comprising a therapeutic agent |
| 10/25/2006 | CN1850800A N-bromo carbazole, and its preparing method |
| 10/25/2006 | CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 10/25/2006 | CN1281586C Carbazyl dithio formate RAFT reagent and its preparation method and use |
| 10/25/2006 | CN1281585C Cyclic diamine compounds having fused-ring groups |
| 10/24/2006 | US7126031 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom |
| 10/24/2006 | US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents |
| 10/24/2006 | US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 10/24/2006 | US7126009 Palladium catalyzed indolization of 2-bromo or chloroanilines |
| 10/24/2006 | US7126008 Carvedilol |
| 10/24/2006 | US7125910 Compounds and compositions for delivering active agents |
| 10/24/2006 | US7125906 Indole derivatives having anti-angiogenetic activity |
| 10/24/2006 | US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 10/24/2006 | US7125840 Substituted dipeptides as growth hormone secretagogues |
| 10/24/2006 | CA2261848C Cell adhesion inhibitors |
| 10/19/2006 | WO2006110668A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 10/19/2006 | WO2006109633A1 Substituted indole compound |
| 10/19/2006 | WO2006109318A1 Novel polymorph of 3-hydroxy-3-(3’-sulfamyl-4’-chlorophenyl)phthalimidine |
| 10/19/2006 | WO2006109147A1 Substantially pure amorphous fluvastatin, processes for its preparation and pharmaceutical compositions containing same |
| 10/19/2006 | WO2006109085A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 10/19/2006 | WO2006108488A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 10/19/2006 | WO2006096810A3 Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3.1.0] hexanes |
| 10/19/2006 | WO2006075139A3 Novel process for the preparation of substituted indoles |
| 10/19/2006 | US20060235222 Indole-derivative modulators of steroid hormone nuclear receptors |
| 10/19/2006 | US20060235220 Dipeptide nitriles |
| 10/19/2006 | US20060235074 Matrix metalloproteinase inhibitors |
| 10/19/2006 | US20060235069 Benzamide modulators of metabotropic glutamate receptors |
| 10/19/2006 | US20060234206 environment-sensitive fluorophores which have spectroscopic behavior that is dependent on the physicochemical properties of the surrounding environment; 6-(Dimethylamino)-2,3-naphthalenedicarboylic anhydride |
| 10/19/2006 | US20060230554 Cyanin-type compounds having an alkynyl linker arm |
| 10/19/2006 | DE112004001502T5 Neurobeschützende und Anti-Proliferationsverbindungen Neurobeschützende and anti-proliferative compounds |
| 10/19/2006 | CA2604291A1 Compounds which inhibit beta-secretase activity and methods of use thereof |
| 10/19/2006 | CA2604042A1 Hydroxybenzamide derivatives and their use as inhibitors of hsp90 |
| 10/19/2006 | CA2602303A1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 10/18/2006 | EP1712548A2 5-amino-4-hydroxy-7-(pyridinylmethyl)-alkanamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
| 10/18/2006 | EP1711465A1 Hydroisoindoline tachykinin receptor antagonists |
| 10/18/2006 | EP1711463A2 Amino-substituted tricyclic derivatives and methods of use |
| 10/18/2006 | EP1711174A1 Adjuvant compositions |
| 10/18/2006 | EP0931063B1 N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 10/18/2006 | CN1849306A Matrix metalloproteinase inhibitors |
| 10/18/2006 | CN1849305A Crystal of sulfonamide-containing indole compound and process for producing the same |
| 10/18/2006 | CN1849304A Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 10/18/2006 | CN1847242A Novel process for producing ramosetron or its salt |
| 10/18/2006 | CN1280291C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |
| 10/18/2006 | CN1280288C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 10/18/2006 | CN1280272C Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 10/18/2006 | CN1280271C Arylphenyl-substituted cyclic keto-enols |
| 10/18/2006 | CN1280267C Sulfonylaminocarboxylic acids |
| 10/17/2006 | US7122684 multi-step process for preparing 2-aminoalcohols from 1,2-epoxides; useful as inhibitors of viral or bacterial neuraminidases; intermediates |
| 10/17/2006 | US7122680 3-Substituted oxindole β3 agonsists |
| 10/17/2006 | US7122679 Multicyclic compounds and the use thereof |
| 10/17/2006 | US7122678 (Trans)-(3,4-Dimethyl-cyclopentyldine)-acetic acid ethyl ester; treating epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, irritable bowel syndrome (IBS), and inflammation |
| 10/17/2006 | US7122677 NK1 antagonists |
| 10/17/2006 | US7122674 Process for preparing high-purity hydroxyindolylglyoxylamides |
| 10/17/2006 | US7122666 Antiinflammatory agents; autoimmune disease; antiarthritic agents |